These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 31550776)

  • 1. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
    Xiang QQ; Yang Z; Huai J; Wang GJ
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):601-607. PubMed ID: 31550776
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of Rheb gene and protein expression in preeclampsia-like mouse model treated with pravastatin].
    Huai J; Yang Z; Yi YH; Wang GJ
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jan; 54(1):38-43. PubMed ID: 30695905
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of mammalian target of rapamycin signaling pathway in regulation of fatty acid oxidation in a preeclampsia-like mouse model treated with pravastatin.
    Huai J; Yang Z; Yi YH; Wang GJ
    Chin Med J (Engl); 2019 Mar; 132(6):671-679. PubMed ID: 30855348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulation of pravastatin on long-chain fatty acid oxidative enzyme in pre-eclampsia-like mouse model].
    Huai J; Yang Z; Yi YH; Wang GJ; Xiang QQ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):183-189. PubMed ID: 29609233
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Effects of Pravastatin on Preeclampsia-like Symptoms in Different Mouse Models.
    Huai J; Yang Z; Yi YH; Wang GJ
    Chin Med J (Engl); 2018 Feb; 131(4):461-470. PubMed ID: 29451152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction.
    Bahtiyar MO; Buhimschi C; Ravishankar V; Copel J; Norwitz E; Julien S; Guller S; Buhimschi IA
    Am J Obstet Gynecol; 2007 Jan; 196(1):72.e1-6. PubMed ID: 17240241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sirtuin 1 deficiency on trophoblasts and its implications in the pathogenesis of pre-eclampsia.
    Yu H; Chen L; Du P; Liu X; Xia Y
    J Obstet Gynaecol; 2023 Dec; 43(2):2282103. PubMed ID: 37966393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity-Enhanced Multimeric VEGF (Vascular Endothelial Growth Factor) and PlGF (Placental Growth Factor) Variants for Specific Adsorption of sFlt-1 to Restore Angiogenic Balance in Preeclampsia.
    Matin M; Mörgelin M; Stetefeld J; Schermer B; Brinkkoetter PT; Benzing T; Koch M; Hagmann H
    Hypertension; 2020 Oct; 76(4):1176-1184. PubMed ID: 32623922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Variation of long-chain 3-hydroxyacyl-CoA dehydrogenase DNA methylation in placenta of different preeclampsia-like mouse models].
    Han Y; Yang Z; Ding X; Yu H; Yi Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Oct; 50(10):740-6. PubMed ID: 26675572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia.
    Tang P; Xu J; Xie BJ; Wang QM
    Hypertens Pregnancy; 2017 Feb; 36(1):48-52. PubMed ID: 27834501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia.
    Akhter T; Wikström AK; Larsson M; Larsson A; Wikström G; Naessen T
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):93-99. PubMed ID: 27256927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
    Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
    J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
    Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
    Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
    Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
    Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia.
    Govender L; Mackraj I; Gathiram P; Moodley J
    Cardiovasc J Afr; 2012 Apr; 23(3):153-9. PubMed ID: 22555639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.